Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Fidia Spa ( (IT:FDA) ) has provided an announcement.
Fidia S.p.A. announced the conversion of five bonds into 217,391 new shares at a price of Euro 0.23 per share, as part of a convertible bond loan with warrants reserved for GGHL. This conversion will increase the company’s share capital by Euro 50,000, bringing the total number of shares to 13,878,109. The move reflects Fidia’s ongoing efforts to strengthen its financial position and enhance its market presence, potentially impacting stakeholders by increasing the liquidity and tradability of its shares.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.50 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A. is a global leader in the design, production, and marketing of high-performance integrated milling systems, primarily serving the mold sector for the automotive and aerospace industries. With over 40 years of experience and approximately 135 employees, Fidia offers comprehensive solutions for the entire milling process, including numerical controls, high-speed milling systems, and CAM software for complex shapes.
Average Trading Volume: 425,965
Technical Sentiment Signal: Strong Sell
Current Market Cap: €1.89M
For an in-depth examination of FDA stock, go to TipRanks’ Overview page.